Diabetes - New Insights into Mechanism of Disease and its Treatment
joint with Adipose Tissue Biology
Organizer(s): C. Ronald Kahn, Jens C. Brüning and Gerald I. ShulmanDate: January 27 - February 01, 2013
Location: Keystone Resort, Keystone, CO, USA
We are in the midst of an epidemic of type 2 diabetes and the closely related metabolic syndrome. These disorders come from a complete interaction between genes and environment which is not fully understood. The goals of this meeting are to address important new areas of research into the primary pathogenesis of these disorders and especially focus on those that might lead to new therapies. The major topics of the meeting are: 1) Mechanisms of metabolic dysfunction and new therapeutic targets for diabetes and obesity; 2) miRNAs in control of metabolism; 3) Aging, mitochondria, and control of metabolism; 4) Epigenetics and perinatal imprinting in diabetes and obesity; 5) CNS control of metabolism; 6) Gastric bypass surgery and the gut in control of metabolism; 7) Metabolic mediators of insulin resistance; and 8) Signaling defects and inflammation in insulin resistance. The major goals of this meeting are to: 1) Make investigators of aware of important new advances in the field of diabetes research; 2) Bring new topics of research from outside the field to the diabetes research community; 3) Stimulate interactions and potential collaborations between participants; and 4) Bring lessons from clinical practice back to the bench. The program should bring new scientific knowledge, new methods and new insights from clinical practice together to stimulate interchange of ideas and even collaborations. Although this meeting has been a regular annual event in the Keystone Symposia series, many of the topics and speakers are new and thus will enrich the field in new ways. The Keystone Symposia Diabetes meeting remains the most important forum for new basic science presentations in the field of diabetes. By bringing it together with the conference on Adipocyte Biology and having multiple joint sessions, this meeting fill a need in the scientific community that is not filled by other conferences. The meeting has novel content that will inform and challenge the attendees and brings many new research paradigms, as well as novel approaches and methods to the scientific community. The meeting is truly interdisciplinary, with not only basic scientists and clinical scientists, but those from many disciplines outside the fields of endocrinology and metabolism, including gastroenterology, neuroscience, innate immunity and genetics.
Scholarship Deadline: September 27 2012
Discounted Abstract Deadline: September 27 2012
Abstract Deadline: October 29 2012
Discounted Registration Deadline: November 28 2012
We gratefully acknowledge additional support for this conference from:
Journal of Lipid Research
We gratefully acknowledge the generous grant for this conference provided by:National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Grant No. 5R13DK084688-04
The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.